Nanoxort, spun out of research conducted at Georgia Tech and Auburn University, develops MRI contrast agents. The firm's contrast agents allow physicians to make more accurate disease diagnoses and provide patients with more personalized and effective treatments. The contact agents produce brighter images for more accurate readings, where contrast agents are used in roughly one-third of MRI procedures to help improve the accuracy for conditions such as inflammatory and infectious diseases. The firm's solution reduces the toxicity of MRI contrast agents and enables fine control of the properties of magnetic nano materials.
